Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Cornely, O. A., Ostrosky-Zeichner, L., Rahav, G., Maher, R., Zeiher, B., Lee, M. and Perfect, J. (2015). Outcomes in Patients with Invasive Mold Disease Caused by Fusarium or Scedosporium spp. Treated with Isavuconazole: Experience from the VITAL and SECURE Trials. Mycoses, 58. S. 196 - 198. HOBOKEN: WILEY-BLACKWELL. ISSN 1439-0507

Marty, F. M., Perfect, J., Cornely, O. A., Mullane, K. M., Rahav, G., Lee, M., Ito, M., Maher, R., Zeiher, B. and Ostrosky-Zeichner, L. (2015). An open-label phase 3 study of isavuconazole (VITAL): focus on mucormycosis. Mycoses, 58. S. 198 - 200. HOBOKEN: WILEY-BLACKWELL. ISSN 1439-0507

Vehreschild, M. J. G. T., Vehreschild, J. J., Marty, F. M., Perfect, J., Ostrosky-Zeichner, L., Rahav, G., Zeiher, B., Lee, M., Maher, R., Lovell, C., Engelhardt, M. and Cornely, O. A. (2015). Primary treatment of invasive mucormycosis (IM) with isavuconazole (VITAL Study) or amphotericin formulations (FungiScopeTM): case matched analysis. Mycoses, 58. S. 197 - 198. HOBOKEN: WILEY-BLACKWELL. ISSN 1439-0507

Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., Jenkin, G., Jensen, W., Kim, Y. -S., Yoshida, J., Gabryelski, L., Pedley, A., Eves, K., Tipping, R., Guris, D., Kartsonis, N. and Dorr, M. -B. (2017). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N. Engl. J. Med., 376 (4). S. 305 - 318. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

This list was generated on Fri Mar 29 03:10:51 2024 CET.